第3代EGFR-TKI耐药后EGFR突变型晚期非小细胞肺癌患者的路在何方
彭 玲, 董晓荣
After third generation EGFR-TKI resistance, where is the path of advanced NSCLC patients with EGFR mutations
PENG Ling, DONG Xiaorong
肿瘤
.
2024, (06): 566
-573
.
DOI: 10.3781/j.issn.1000-7431.2024.2404-0180
